# A data-driven financial justification for an outpatient infectious diseases pharmacist

## TL;DR

This paper shows how hiring an outpatient infectious diseases pharmacist can save money and generate revenue in healthcare.

## Contribution

The study provides a data-driven financial case for employing outpatient infectious diseases pharmacists.

## Key findings

- Reduced length of stay for patients with Staphylococcus aureus infections led to cost savings.
- Outpatient parenteral antimicrobial therapy generated additional revenue for healthcare providers.

## Abstract

We present a financial justification for an outpatient infectious diseases pharmacist, based on cost savings from decreases in length of stay for patients with Staphylococcus aureus infections and additional revenue generated by physicians and pharmacists while following patients discharged on outpatient parenteral antimicrobial therapy.